About NeuroSync (formerly SyncThink)

NeuroSync (formerly SyncThink) is a neurotechnology firm that provides a digital health platform for brain health applications, leveraging artificial intelligence and objective measures. Their core business involves a platform that utilizes AI and objective measurements to assess brain health, provide therapy, and enhance cognitive performance. This technology is designed to assist clinicians, researchers, and high-performance specialists with actionable data for identifying neurological deficits, monitoring treatment responses, and planning targeted training programs.

This platform provides objective data to aid in the assessment of brain health and performance, with assessments that can be completed rapidly, often in under a minute. It offers a comprehensive assessment tool that includes ocular-motor, ocular-vestibular, SCAT 5, and BESS assessments to examine brain health. NeuroSync also offers PRO-SYNC, a non-medical wellness application that tracks and enhances sleep quality and mental acuity by monitoring eye movements, providing a readiness score. This is intended for general wellness and not for medical diagnosis or treatment.

Focus Areas

Concussion diagnosis brain health performance optimization neurodegenerative conditions autoimmune disorders developmental disorders visual and vestibular therapies sports military biopharma digital health AI eye-tracking

Business Intelligence

TechnologyDigital health platform, Artificial Intelligence (AI), objective measures, eye-tracking technology (EYE-SYNC), Virtual Reality (VR)/Extended Reality (XR) headsets, proprietary algorithms, cloud-based solution, Android-based software application

What Physicians Need to Know

Concussion Diagnosis
NeuroSync's EYE-SYNC® technology is an FDA-cleared assessment battery that uses eye-tracking within a virtual reality (VR) headset to aid in concussion diagnosis. It objectively measures eye movements to identify visual tracking impairments, which are common deficits after a concussion. The system provides rapid, objective data (assessments can be completed in under a minute) and has received Breakthrough Device Designation from the FDA. It's used to evaluate concussion recovery and facilitate safe return-to-play protocols, offering individualized treatment plans.
Brain Health
NeuroSync provides objective neurological measurements to assess brain health, delivering therapies, and enhancing cognitive function. Their platform leverages AI and proprietary measures to identify deficits, monitor drug responses, and plan training. They also offer a non-medical wellness application, PRO-SYNC, to track and enhance sleep quality and mental acuity by monitoring eye movements.
Performance Optimization
The NeuroSync platform is used for proactively monitoring fatigue, screening for impairment, and training for enhancing dynamic vision. It quantifies athlete readiness and provides actionable data to optimize performance and decrease the risk of injury. This includes evaluating balance, visual targeting, proprioception, and head movement, particularly in sports like golf.
Neurodegenerative Conditions
NeuroSync aims to provide objective neurological measurements for neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease. They are also involved in research and development related to neural repair.
Autoimmune Disorders
NeuroSync addresses autoimmune disorders such as Multiple Sclerosis.
Developmental Disorders
NeuroSync's technology is being applied to developmental disorders such as ADHD, with ongoing clinical studies for biomarker identification. They also address Autism Spectrum Disorder.
Visual and Vestibular Therapies
NeuroSync's EYE-SYNC technology is a critical tool in vestibular-ocular assessment and treatment. Their platform can be used to identify and remediate impairments, and individualized treatment plans may include vestibular therapy and vision training.
Sports
NeuroSync is widely used by leading collegiate and professional sports organizations for concussion management, athlete readiness, and performance optimization. They have partnerships with organizations like the XFL for concussion protocols.
Military
NeuroSync drives the optimization of active duty personnel and has collaborated with the US Department of Defense.
Biopharma
NeuroSync accelerates innovation in CNS trials and beyond for biopharmaceutical companies.
Digital Health
NeuroSync offers a digital health platform that leverages AI and objective measures for brain health applications, delivering therapy, and optimizing performance. Their platform is cloud-connected and HIPAA compliant.
AI
NeuroSync harnesses the power of AI to develop revolutionary eye-tracking software and analytic technologies. Their AI-driven analytics can predict cognitive patterns and are used in their proprietary algorithms and deep learning models for concussion diagnosis.
Eye-Tracking
Eye-tracking is foundational to NeuroSync's technology, particularly with their EYE-SYNC platform. It objectively measures brain health and performance by analyzing eye movements, providing high-fidelity insight into cognition.
Physician Tip

NeuroSync offers physicians an objective, rapid, and reliable tool for assessing brain health and diagnosing conditions like concussions, backed by extensive clinical research and FDA clearance. The EYE-SYNC platform provides actionable data to identify deficits, monitor treatment responses, and create individualized therapy plans, particularly for visual and vestibular impairments. Its ease of use and portability (VR-based, wireless) allow for assessments in various settings. For neurodegenerative and developmental disorders, NeuroSync's AI-driven eye-tracking offers potential for early detection and monitoring. Physicians can also leverage the platform for performance optimization in athletes and military personnel, and for accelerating CNS trials in biopharma. Becoming a certified EYE-SYNC provider can demonstrate proficiency and distinguish practices.

NeuroSync's EYE-SYNC platform is a virtual reality-based eye-tracking system that integrates with a tablet for data input and reporting. It is cloud-connected and HIPAA compliant. NeuroSync has partnered with AR leader Magic Leap for co-development of a platform for vestibular disorders. They also collaborate with Pico Interactive and Tobii for their VR solutions. The platform is designed for customizable assessment workflows and multisensory training environments.

Products by NeuroSync (formerly SyncThink)

No products listed for this company yet. Know of one? Suggest it →

Videos

News, demos, and interviews about NeuroSync (formerly SyncThink).

Loading videos...

Videos load interactively. If none appear, search YouTube for NeuroSync (formerly SyncThink) →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

NeuroSync's core technology is EYE-SYNC®, an FDA-cleared, proprietary eye-tracking technology that uses patented algorithms and AI within a virtual reality (VR) headset to objectively measure brain health and performance. It assesses eye movements to identify disorientation and visual tracking impairments, which aids in concussion diagnosis and helps clinicians monitor recovery and plan treatment.
NeuroSync's EYE-SYNC platform provides real-time data and analytics on orientation and offers training tools to improve performance. By identifying issues rapidly, specific strategies can be implemented to remediate impairment and optimize brain function, which is crucial for visual and vestibular therapies and can accelerate recovery time.
NeuroSync's EYE-SYNC is an FDA-cleared technology for aid in concussion diagnosis and visual impairment identification. It is also cloud-connected and HIPAA compliant, ensuring data privacy and adherence to healthcare regulations.
NeuroSync's business model involves providing access to its proprietary software and analytics, generating revenue from partnerships and the sale of its integrated technology solutions. They have partnered with organizations like Stanford University, Magic Leap, and the Department of Defense, and also collaborate with sports teams and biopharmaceutical companies.
NeuroSync, formerly SyncThink, rebranded in 2022 under a new executive team to accelerate growth in the broader neuro-healthcare landscape. The company is venture capital-backed and aims to transform neuro health by delivering objective and actionable data to providers, expanding accessibility, and improving patient outcomes for neuro health disorders.
While EYE-SYNC is FDA-cleared as an aid for concussion diagnosis and visual impairment, NeuroSync is also sponsoring ongoing clinical studies toward the development of a biomarker identification platform for Attention Deficit Hyperactivity Disorder (ADHD). Additionally, some of their advisors have expertise in neurodegenerative conditions like Alzheimer's and Parkinson's, autoimmune disorders such as Multiple Sclerosis, and developmental disorders like ADHD, indicating a broader interest in these areas.
NeuroSync provides formal training to all users of the EYE-SYNC technology, often in-person at the clinical site. They also offer real-time clinical and technical support, and clinicians can become certified EYE-SYNC providers upon completion of the training.

Related Companies

Stanford University, through its online learning platform Stanford Online (online.stanford.edu), provides a wide array of educational opportunities, including those focused on Artificial Intelligence (AI) in healthcare. Stanford Online aims to extend the university’s academic excellence and breakthrough research to a global audience, offering programs taught by Stanford faculty and industry experts. These offerings range from […]

RTW.ai provides scaled CPA services, offering productized accounting, tax preparation, and quarterly insights specifically for owner-led businesses in healthcare, professional services, and the trades. The company aims to eliminate the common frustrations associated with traditional accounting services, such as slow response times and lack of proactive tax planning. They commit to closing books by the […]

Infinitus is a healthcare AI company that develops voice AI agents and copilots to automate administrative workflows for physicians and healthcare providers. The company aims to reduce the complexity and cost of healthcare by handling time-consuming and repetitive phone-based tasks, such as benefit verifications, prior authorizations, patient outreach, and member engagement. By automating these processes, […]

Trainio is an AI roleplay training platform specifically designed for healthcare teams. It allows medical staff, including front desk personnel, call center agents, caregivers, nurses, and pharmacists, to practice challenging patient and family conversations with realistic AI avatars. These scenarios cover a wide range of situations, such as de-escalation of angry patients, communication with individuals […]

Confido Health is an AI-powered healthcare operations platform designed to alleviate administrative burdens for physicians and healthcare providers. The company develops AI agents that automate routine tasks and workflows across various aspects of healthcare operations, including front, mid, and back office functions. This allows medical staff to dedicate more time to direct patient care, improving […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.